Immunitybio Inc is trading 4.1% down at $6.84 as the stock gives back a portion of last week’s gains despite an absence of fresh, company-specific headlines.
- The move follows a modest +0.42% close at $7.13 on June 15, 2026.
- Today's price action suggests traders may be locking in profits or reacting to recent technical weakness rather than new fundamental developments.
- The decline occurs against a mixed broader market backdrop with no new catalysts identified this morning.